Regarding the glycemic control efficiency of these three basal insulin analogs, a meta-analysis was conducted to compare glargine, detemir, and degludec with respect to their glycemic control in type 1 and type 2 diabetes. The gene discussed is INS; the disease is type 2 diabetes mellitus.